Page contentsKey factsDecisionKey factsActive SubstanceAcotiamideTherapeutic areaGastroentology-HepatologyDecision numberP/0213/2013PIP numberEMEA-001461-PIP01-13Pharmaceutical form(s)Coated tabletCondition(s) / indication(s)Treatment of functional dyspepsiaRoute(s) of administrationOral useContact for public enquiriesZeria Pharmaceutical Co Ltdtomoharu-miyagawa@zeria.co.jpTel. +44 (0)7528 697428Decision typeRW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)Decision date05/09/2013DecisionP/0213/2013: EMA decision of 3 September 2013 on the refusal of a product-specific waiver for acotiamide (EMEA-001461-PIP01-13)AdoptedReference Number: EMA/515460/2013 English (EN) (80.14 KB - PDF)First published: 08/10/2013Last updated: 08/10/2013ViewShare this pageHow useful do you find this page?12345